Suggested remit: To appraise the clinical and cost effectiveness of Oleogel-S10 within its marketing authorisation for treating skin wounds associated with epidermolysis bullosa.
Status In progress
Technology type Medicine
Decision Selected
Reason for decision Anticipate the topic will be of importance to patients, carers, professionals, commissioners and the health of the public to ensure clinical benefit is realised, inequalities in use addressed, and help them make the best use of NHS resources
Process STA 2022
ID number 1505

Project Team

Project lead Emily Richards

Email enquiries


Key events during the development of the guidance:

Date Update
18 May 2022 Topic selection
18 May 2022 The topic was discussed at the Topic Selection Oversight Panel (TSOP) in October 2021. The panel concluded that the topic was suitable for a Highly Specialised Technologies (HST) evaluation The evaluation is anticipated to start in August 2022 and the deadline for submissions is expected in approximately early November 2022.
18 May 2022 Awaiting development. Status change linked to Topic Selection Decision being set to Selected
18 May 2022 In progress. Topic progressing.
07 September 2020 (14:00) Scoping workshop
13 July 2020 - 10 August 2020 Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentators

For further information on our processes and methods, please see our CHTE processes and methods manual